• FDA-EMA Virtual Seminiar Series - Announcement & Registration

FDA-EMA 4-part virtual seminar series – March 22, April 19, May 17 and June 14, 2021

starts:22/03/2021 ends:22/03/2021 from:14:00 to:18:00 organizer: address:Virtual mobile:+1 202 797 5310 email: Import to calendar

Venue: Virtual

Date: 22/03/2021

Time: 14:00 - 18:00


The Embassy of Denmark in Washington, DC and The Danish Medicines Agency are proud to present a 4-part virtual seminar series in collaboration with the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Each session will focus on a specific theme addressing related topics and incorporate recent examples and relevant cases. Sessions will be interactive with a Q&A period following each presentation. Below are the session titles and a detailed description of each can be read in the Announcement Registration attached in the Agenda section.

Session 1 – March 22 2021
Transatlantic Cooperation in Medical Products Regulation

Session 2 – April 19 2021
What’s new in Oncology

Session 3 – May 17 2021
Patients in Drug Development & Regulatory Processes

Session 4 – June 14 2021
Innovations in Therapy & Digital Transformations

Why attend:

  • Hear the latest developments in regulatory science directly from FDA & EMA
  • Follow current trends in adapting regulations in the development and innovation of drugs and medical technologies
  • Understand critical changes underway to create successful strategies in the USA & Europe
  • Benchmark your regulatory strategies against agency requirements
  • Reserve a brief private one on one meeting with FDA & EMA officials

Who should attend:

  • Professionals in Research & Development, Regulatory Affairs, Medical Affairs, Corporate Strategy & Business Development, Market Access & Policy, Health Technology and Patient Advocacy

In the attached announcement registration, you can read more about:

  • Session Descriptions
  • Session 1 Program & Speakers
  • Background on the 4-part series & practical information
  • Registration Form & Reservation for 1:1 meetings with speakers

Practical information: 
The registration fee of DKK 1500 per person includes participation in all sessions, materials, a certificate of participation, session recordings, and the opportunity for a brief 1:1 consultation with FDA/EMA officials. Registration for single sessions is not allowed . Deadline for registration is March 18, 2021

For more information contact:
Elizabeth Dempsey Becker
Team Leader, Health & Life Sciences North America
Embassy of Denmark, Washington, DC
Phone: +1 202 797 5310

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 7172 1114

Copyright 2021 DANISH BIO – DANSK BIOTEK. All rights reserved.